Markets on edge as tariff deadline looms & the future of vaccine development in the FDA 3/31/25

The S&P and Dow eked out a gain on Monday but all indexes closed the quarter with significant losses. This as investors await the onset of President Trump’s tariffs and the announcement of reciprocal levies. Plus the FDA’s vaccine head abruptly resigned over the weekend. What that means for drug development in the U.S. Fast Money Disclaimer